Use of psychotropic medications for dementia patients

​Request 719460770

A review of the use of psychotropic medications for dementia patients admitted to the General Hospital was completed in Q1 2024, and more in-depth audit based on the National Audit of Dementia Psychotropic Medications was also undertaken and completed last year. 

A final report was compiled, and learning from the audit was due to be shared with clinicians in February 2025. 

A spotlight audit was also completed in July 2024 reviewing key aspects of care for inpatients at the General Hospital, on one identified day, with a diagnosis of dementia.

Please provide a copy of all of these documents: the psychotropic medications review report, the in-depth audit final report, and the spotlight audit report.

Response

The report produced on the audit of psychotropic medication prescribing practices in those with a diagnosis of dementia is attached. This is the sole report produced.

The audit completed at Jersey General Hospital ‘was designed to allow comparisons with the Spotlight Audit on Psychotropic Medication in Dementia Care conducted by the Royal College of Psychiatrists, while tailoring the approach to the Jersey healthcare system.’

Freedom ​of Informaion response 719460770 - Attachment.pdf​

In consideration of Freedom of Information legislation, redactions have been applied to the document. Article 25 of the Freedom of Information (Jersey) Law 2011 has been applied to protect the privacy of individuals, and personal information and detail which could identify individuals, including patients and staff, is redacted in yellow.

​Article applied

Article 25 - Personal information

(1) Information is absolutely exempt information if it constitutes personal data of which the applicant is the data subject as defined in the Data Protection (Jersey) Law 2018.

(2) Information is absolutely exempt information if –

(a) it constitutes personal data of which the applicant is not the data subject as defined in the Data Protection (Jersey) Law 2018; and

(b) its supply to a member of the public would contravene any of the data protection principles, as defined in that Law.​​​